Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.

Hammers, Dustin B; Lin, Joshua H; Polsinelli, Angelina J; Logan, Paige E; Risacher, Shannon L; Schwarz, Adam J; Apostolova, Liana G

Hammers, Dustin B; Lin, Joshua H; Polsinelli, Angelina J; Logan, Paige E; Risacher, Shannon L; Schwarz, Adam J; Apostolova, Liana G.

Afiliação

Hammers DB; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Lin JH; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Polsinelli AJ; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Logan PE; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Risacher SL; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Schwarz AJ; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Apostolova LG; Takeda Pharmaceuticals Ltd., Cambridge, MA, USA.

J Alzheimers Dis ; 96(1): 197-214, 2023.

Article em En | MEDLINE | ID: mdl-37742649

Assuntos

Doença de Alzheimer; Disfunção Cognitiva; Humanos; Doença de Alzheimer/patologia; Proteínas tau; Peptídeos beta-Amiloides; Disfunção Cognitiva/diagnóstico; Cognição

Palavras-chave

Alzheimer's disease; amyloid; learning; memory; mild cognitive impairment; tau

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google